John Sadler - Tilray Vice Relations

TLRY Stock  USD 1.31  0.02  1.55%   

Executive

John Sadler is Vice Relations of Tilray Inc
Address 265 Talbot Street West, Leamington, ON, Canada, N8H 5L4
Phone844 845 7291
Webhttps://www.tilray.com

Tilray Management Efficiency

The company has return on total asset (ROA) of (0.014) % which means that it has lost $0.014 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0584) %, meaning that it created substantial loss on money invested by shareholders. Tilray's management efficiency ratios could be used to measure how well Tilray manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.15 in 2024. Return On Capital Employed is likely to drop to -0.17 in 2024. At this time, Tilray's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 66.6 M in 2024, whereas Total Current Assets are likely to drop slightly above 396.4 M in 2024.
Tilray Inc currently holds 387.32 M in liabilities with Debt to Equity (D/E) ratio of 0.14, which may suggest the company is not taking enough advantage from borrowing. Tilray Inc has a current ratio of 3.26, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Tilray's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Thomas IVCanopy Growth Corp
35
Navroop SandhawaliaSNDL Inc
Jonathan PageAurora Cannabis
55
Neil BelotAurora Cannabis
N/A
Jurgen BickelCanopy Growth Corp
N/A
Arye WeigensbergCronos Group
41
Jenny BrewerCanopy Growth Corp
N/A
Helen MartinOrganiGram Holdings
46
Nathalie BattenOrganiGram Holdings
N/A
Megan McCraeOrganiGram Holdings
N/A
Deanna GarandSNDL Inc
41
Dave AirdAurora Cannabis
N/A
Simona KingAurora Cannabis
52
Simona CPAAurora Cannabis
52
Michelle LeflerAurora Cannabis
N/A
Adam WagnerCronos Group
41
Shannon BuggyCronos Group
54
Mark WareCanopy Growth Corp
N/A
Sophie PilonSNDL Inc
N/A
Chris EdwardsCanopy Growth Corp
N/A
Katrina McFaddenOrganiGram Holdings
N/A
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. Tilray Brands is traded on NASDAQ Exchange in the United States. Tilray Inc (TLRY) is traded on NASDAQ Exchange in USA. It is located in 265 Talbot Street West, Leamington, ON, Canada, N8H 5L4 and employs 2,650 people. Tilray is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Tilray Inc Leadership Team

Elected by the shareholders, the Tilray's board of directors comprises two types of representatives: Tilray inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tilray. The board's role is to monitor Tilray's management team and ensure that shareholders' interests are well served. Tilray's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tilray's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lloyd Brathwaite, Chief Officer
CPA CMA, President Canada
Randy Daigneau, Senior Chain
Irwin Simon, CEO President
Mitchell Gendel, Global Secretary
John Sadler, Vice Relations
Nyree Pinto, Chief Officer
James Meiers, Sr Operations
CA CBV, CFO Officer
Dara Redler, Interim Sec
Bernard Yeung, VP Marketing
Denise Faltischek, Chief International
Berrin Noorata, Chief Officer
Mitchell JD, Global Secretary
Roger Savell, Chief International

Tilray Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tilray a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tilray Stock Analysis

When running Tilray's price analysis, check to measure Tilray's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tilray is operating at the current time. Most of Tilray's value examination focuses on studying past and present price action to predict the probability of Tilray's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tilray's price. Additionally, you may evaluate how the addition of Tilray to your portfolios can decrease your overall portfolio volatility.